ADVFN ADVFN

Hot Features

Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
abrdn Life Sciences Investors

abrdn Life Sciences Investors (HQL)

16.92
-0.35
(-2.03%)
終了 6月6日 5:00AM
17.00
0.08
(0.47%)
取引時間後: 8:56AM

abrdn Life Sciences Investors (HQL) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
17.00
( -1.56% )
買値
-
売値
-
出来高
127,018
16.5901 日の範囲 17.285
12.34 52 週間の範囲 18.46
時価総額
前日終値
17.27
始値
17.25
最終取引時間
財務取引量
US$ 2,167,021
VWAP
17.0607
平均取引量 (3 か月)
US$ 107,071
発行済株式数
30,408,047
配当利回り
1.82 (11.00%)
PER
6.18
1 株当たり利益 (EPS)
2.89
歳入
1.94M
純利益
85.59M

abrdn Life Sciences Investors について

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics,... Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. 詳細を表示

セクター
Finance
業界
Asset Management Services
本社
Philadelphia, United States
設立
1992
abrdn Life Sciences Investors is listed in the Finance sector of the ニューヨーク証券取引所 with ticker HQL. The last closing price for abrdn Life Sciences Inve... was US$17.27. Over the last year, abrdn Life Sciences Inve... shares have traded in a share price range of US$ 12.34 to US$ 18.46.

abrdn Life Sciences Inve... currently has 30,408,047 shares in issue. The market capitalisation of abrdn Life Sciences Inve... is US$516.94 million. abrdn Life Sciences Inve... has a price to earnings ratio (PE ratio) of 6.18.

HQL 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.76-4.2792792792817.7617.9116.6410101717.29671331CS
4-1.03-5.712701053818.0318.4616.4410594917.60269509CS
120.352.102102102116.6518.4615.819410163517.27548166CS
26-0.29-1.6772700983217.2918.4615.6611790217.03751009CS
524.4335.242641209212.5718.4612.3413369515.96626671CS
1563.42513.618.4610.550111591014.41617728CS
260-3.04-15.169660678620.0422.710.550110122615.07215636CS

HQL - Frequently Asked Questions (FAQ)

What is the current abrdn Life Sciences Investors share price?
The current share price of abrdn Life Sciences Investors is US$ 17.00
How many abrdn Life Sciences Investors shares are in issue?
abrdn Life Sciences Investors has 30,408,047 shares in issue
What is the market cap of abrdn Life Sciences Investors?
The market capitalisation of abrdn Life Sciences Investors is USD 516.94M
What is the 1 year trading range for abrdn Life Sciences Investors share price?
abrdn Life Sciences Investors has traded in the range of US$ 12.34 to US$ 18.46 during the past year
What is the PE ratio of abrdn Life Sciences Investors?
The price to earnings ratio of abrdn Life Sciences Investors is 6.18
What is the cash to sales ratio of abrdn Life Sciences Investors?
The cash to sales ratio of abrdn Life Sciences Investors is 280.17
What is the registered address of abrdn Life Sciences Investors?
The registered address for abrdn Life Sciences Investors is 1900 Market Street, Philadelphia, Pennsylvania, 19103
Which industry sector does abrdn Life Sciences Investors operate in?
abrdn Life Sciences Investors operates in the Asset Management Services sector

HQL 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock